BCAX – bicara therapeutics inc. (US:NASDAQ)
Stock Stats
News
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook [Yahoo! Finance]
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook
Bicara Therapeutics (NASDAQ:BCAX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Bicara Therapeutics (BCAX) Valuation After Dual Biotechnology Index Additions [Yahoo! Finance]
Form 8-K Bicara Therapeutics Inc. For: Jan 12
Form 4 Bicara Therapeutics Inc. For: Dec 26 Filed by: Cohlhepp Ryan
Form 4 Bicara Therapeutics Inc. For: Dec 26 Filed by: Raben David
Form 4 Bicara Therapeutics Inc. For: Dec 22 Filed by: Hyep Ivan
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.